What are the long-term effects of taking sertraline (Zoloft) for an extended period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Long-Term Effects of Sertraline (Zoloft)

Sertraline is generally well-tolerated for long-term use, with the FDA approving extended treatment for various conditions, though patients should be periodically reassessed to determine continued need for the medication 1.

Common Long-Term Side Effects

Sertraline may cause several persistent side effects with extended use:

  • Gastrointestinal effects: Nausea, diarrhea, and digestive disturbances may occur but typically decrease in frequency with continued treatment 2
  • Sexual dysfunction: Primarily ejaculatory disturbances in males, which can persist throughout treatment 2
  • Sleep disturbances: Insomnia or somnolence may continue with long-term use 3
  • Central nervous system effects: Headaches, dizziness, and fatigue 2

Safety Profile for Extended Use

Sertraline has several advantages for long-term treatment:

  • Minimal anticholinergic activity: Less dry mouth, constipation, and cognitive effects compared to tricyclic antidepressants 2
  • Cardiovascular safety: Essentially devoid of cardiovascular effects, making it suitable for elderly patients or those with underlying cardiovascular disorders 2
  • Wide therapeutic index: Favorable safety profile in overdose compared to other antidepressants 2
  • Minimal drug interactions: Compared to other SSRIs, sertraline has less effect on the metabolism of other medications 4

Duration of Treatment Considerations

The FDA label provides specific guidance on maintenance treatment:

  • Major Depressive Disorder: Efficacy maintained for up to 44 weeks following 8 weeks of initial treatment 1
  • Post-traumatic Stress Disorder: Efficacy maintained for up to 28 weeks following 24 weeks of treatment 1
  • Social Anxiety Disorder: Efficacy maintained for up to 24 weeks following 20 weeks of treatment 1
  • Obsessive-Compulsive Disorder and Panic Disorder: Benefit demonstrated for up to 28 weeks of maintenance treatment 1

Monitoring During Long-Term Treatment

Regular monitoring is essential during extended sertraline use:

  • Periodic reassessment: The FDA recommends periodic reevaluation to determine the continued need for the medication 1
  • Dosage adjustments: Patients should be maintained on the lowest effective dose 1
  • Suicidal ideation: Particularly important in patients under 24 years of age 3
  • Withdrawal symptoms: Abrupt discontinuation may lead to withdrawal reactions; tapering over 10-14 days is recommended when stopping treatment 4

Special Populations

  • Hepatic impairment: Lower or less frequent dosing may be required in patients with liver disease 1
  • Elderly patients: Starting at lower doses (25mg) and titrating more slowly is recommended 3
  • Pregnant women: Sertraline has a relatively favorable safety profile compared to other antidepressants 3

Discontinuation Considerations

When discontinuing sertraline after long-term use:

  • Gradual tapering: Discontinuing over 10-14 days limits withdrawal symptoms 4
  • Monitoring for relapse: Studies show relapse rates of 41% during long-term treatment compared with 60% after short-term therapy 5
  • Symptom severity: Patients with more severe baseline symptoms are more likely to relapse after discontinuation 5

Conclusion

Sertraline is generally safe and effective for long-term use, with a favorable side effect profile compared to many other antidepressants. However, patients should be regularly reassessed to determine the ongoing need for medication, and any discontinuation should be gradual to minimize withdrawal symptoms.

References

Guideline

Anger Management and Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.